BINA DAILY · 2026-07-09
Today: AI policy and product news, plus the latest in health and medicine.
|
BINA DAILY · 2026-07-09
|
|
AI BRIEF
Anthropic Tops OpenAI, Regulators Target AI Agents on Three Fronts
Anthropic edges past OpenAI in revenue; China, BoE, and FTC tighten controls on AI agents — plus a physics breakthrough.
IN TODAY'S BRIEF
- Anthropic Overtakes OpenAI in Revenue and Secondary-Market Valuation
- OpenAI Proposes Giving the US Government a 5% Equity Stake
- China Orders AI Companion Apps to Shut Down Personalized Agents by July 15
- Bank of England Warns AI Agents Could Amplify Market Volatility and Explores 'Kill Switches'
- FTC: Hidden AI Output Steering Is a Deceptive Practice
- Enterprise AI Adoption Is Outpacing Governance by a Wide Margin
- Vision-Language AI Solves a Physics Mystery That Stumped Scientists for Decades
Read the full AI brief →
|
|
|
HEALTH ROUNDUP
AI Designs the Vaccine, Discovers the Drug, and Manages the Bill: Health AI This Week
A historic AI-designed vaccine trial, the first fully AI-discovered Phase III drug, and $110M for Medicare AI — this week in health.
IN TODAY'S BRIEF
- World's First AI-Designed Vaccine Completes Early Human Trial With Broad Coronavirus Protection
- Insilico Medicine's Rentosertib Enters Phase III — A First for Fully AI-Discovered Drugs
- Weill Cornell's EmulatRx Uses Real-World Patient Data to Make Clinical Trials Faster and Cheaper
- Evogene and Tel Aviv University Pair Generative Chemistry AI With Experimental Biology
- Pearl Health Raises $110M to Scale AI Managing $3.6B in Medicare Spend
- Philips Alturion Ultrasound System Earns FDA and CE Clearance for AI-Powered Imaging
Read the full health roundup →
|
